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Abstract: 
The purpose of this research was to determine whether a group of African Americans who had 
no diagnosis of type 2 diabetes had elevated blood glucose levels and other risk factors indicative 
of type 2 diabetes. A convenience sample of 20 African American adults 50 years and older 
participated in the pilot study. Participants were screened for elevated fasting capillary blood 
glucose levels and related risk factors such as hypertension, high cholesterol levels, and high 
body mass index. Frequency data indicated that at least 50% of participants had capillary glucose 
levels greater than 110 mg/dL. An overwhelming majority of the participants with elevated 
glucose levels had one or more other risk factors for type 2 diabetes. Evidence-based practice 
clearly indicates that an early detection and control of type 2 diabetes can prevent complications 
and also help prevent coronary artery disease.  
 
Article: 
There is an abundant amount of recent research that clearly demonstrates the positive effects that 
early detection and strict glycemic control can have on preventing the complications associated 
with type 2 diabetes.
1-4
 The American Diabetes Association Clinical Practice Recommendations 
2001 state that early detection, along with adequate treatment, has the potential to greatly reduce 
the side effects and complications from type 2 diabetes.
5
 For this reason, the American Diabetes 
Association (ADA) advocates screening susceptible populations that include African Americans, 
especially African American women. The purpose of this research was to determine whether a 
group of African Americans, who had no previous diagnosis of type 2 diabetes, had elevated 
blood glucose levels and other risk factors indicative of type 2 diabetes. The participants’ ages 
ranged from 50 to 88 years, and the majority were aged 65 years or older. Participants were 
living in financially subsidized public and private independent living centers. 
 
BACKGROUND 
Type 2 diabetes is rapidly reaching epidemic proportions in the United States and is considered 
the fourth leading cause of death. With a prevalence rate of 7.4% of the total population, the rate 
of diabetes mellitus is expected to rise to 8.9% by the year 2025.
6
 It is estimated that nearly 10.3 
million Americans have been given a diagnosis of diabetes and as many as 5.4 million cases 
have remained undiagnosed. The annual cost of treating direct and indirect medical 
complications is $90 billion.
6,7
 Type 2 diabetes accounts for 85% to 90% of all cases of diabetes 
and disproportionately affects the African American population. More than 3 million African 
Americans, including 8.5% of African American males and 12.1% of African American females, 
as compared with 2.5% to 8.4% of white Americans, have diabetes.
6,7
 The incidence of type 2 
diabetes greatly increases with age. Regrettably, the disease can remain asymptomatic and 
undiagnosed for many years. During this time, the individual is at significant risk for diseases 
that are direct results of type 2 diabetes such as retinopathy, nephropathy, and neuropathy. There 
is also a significant risk for development of diseases associated with the indirect effects of type 2 
diabetes, including coronary artery disease, stroke, and peripheral vascular disease. Studies have 
shown that African Americans are substantially more likely to experience blindness and end-
stage renal disease and to require lower-limb amputations than those in other populations with a 
diagnosis of type 2 diabetes.
6-9 
 
CLINICAL PRESENTATION IN OLDER ADULTS 
One reason type 2 diabetes is often not detected in older adults is that the classic symptoms 
associated with hyperglycemia are not evident. Older adults often experience decreased thirst; 
therefore, primary care providers may ex pect classic complaints of thirst, not usual among the 
very old. In older adults glucose may not be detected in the urine until osmolar glycemic levels 
are extremely elevated. Symptoms are most often nonspecific, such as confusion, failure to 
thrive, and incontinence. Older adults with type 2 diabetes may be less obese than their younger 
counterparts. Many older adults with type 2 diabetes also have hypertension. 
10,11
 
 
One should consider type 2 diabetes when examining older adults with skin infection, joint pain, 
or neuropathies and those with macrovascular and microvascular diseases such as stroke and 
heart disease.
11
 Identification and treatment of type 2 diabetes will greatly reduce the risk of car-
diovascular morbidity and death.
12
 Recent studies also indicate that older adults treated for 
diabetes may experience improvement in cognition.
13 
 
SCREENING OLDER ADULTS 
According to the National Health and Nutrition Examination Survey, NHANES 1II, it is 
estimated that 20% of the United States population will have type 2 diabetes by the age of 75 
years.
11
 Compounding this problem is the fact that the majority of older adults are unaware that 
they have the disease.
11
 Screening for type 2 diabetes allows detection of the disease when it is 
still asymptomatic. Appropriate interventions can then be started, which will improve the 
prognosis. Screening for type 2 diabetes has a greater benefit when it is done to identify those 
who are more likely to be at risk and when the screening uses measurements that keep costs 
down. Because the incidence of type 2 diabetes among older African Americans has reached 
alarming rates with increasingly detrimental outcomes, screening this population appears 
prudent. Studies have shown that using a fasting capillary whole blood glucose measure by 
means of a finger stick is the most cost- effective means of conducting a community-wide screen 
for diabetes. 14,15 
 
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1999) states 
that a fasting plasma glucose level of >126 mg/dL on more than one occasion is needed for the 
diagnosis of diabetes. Because plasma glucose readings require a sample of venous blood, the 
majority of screening programs use fasting capillary whole blood glucose readings, which 
require only a finger stick. Up to 90% of individuals with diabetes are identified with the use of 
this method.
 16
 It has been shown that a fasting whole blood glucose measurement has a 
sensitivity of 69% to 90% and a specificity of 90% or greater. However, fasting plasma blood 
glucose levels tend to be 10% to 15% higher than whole blood glucose levels. Therefore, fasting 
capillary whole blood glucose levels have been deemed valid and reliable means of 
screening.
14,15
 Those with a fasting capillary whole blood level of ≥110 mg/dL should be 
considered at risk for diabetes and referred for further evaluation.
1,17
 Further, the Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus (1999) 
 
recommends that screenings for diabetes are enhanced when they are done in conjunction with 
screenings for other risk factors associated with the disease such as high cholesterol levels, 
hypertension, and obesity.
16 
 
Results from a recent study indicate that the prevalence of undiagnosed type 2 diabetes among 
people aged 45 to 65 years is greater among those who have at least three risk factors—primarily 
obesity, hypertension, and a positive family history of diabetes. 
10,16
 Obesity has been identified 
as a major health concern among all populations in the U.S. Department of Health and Human 
Services (2000) Healthy People 2010 Objectives.
18 
 
CONCEPTUAL FRAMEWORK 
Nola Pender’s health promotion model, which integrates nursing and behavioral science 
perspectives, was used as the theoretical basis for this study.
19
 The health promotion model 
identifies the cognitive-perceptual factors within an individual that are modified by personal, sit-
uational, and interpersonal characteristics to result in participation in health-promoting 
behaviors. The seven major concepts of age, education, gender, income, body weight, family 
patterns of health care, and expectations of significant others all play a role in determining health 
care behaviors (Table 1). 
 
METHODS 
Setting and Sample 
A convenience sample was selected from among the total number of residents at two 
independent living longterm care retirement centers. The majority of residents were African 
American women with few financial resources. Criteria for inclusion in the study included 
African American ethnicity, age 50 years or older, no previous diagnosis of diabetes, and the 
ability to give both written and oral consent. The sample consisted of 20 African American older 
adults (N = 20), 4 men and 16 women. The age range of the female participants was 56 to 88 
years with a mean age of 74 years. The age range of male participants was 52 to 90 years with a 
mean age of 69 years. 
 
Design 
A descriptive correlational study design was used to identify participants who had not been 
previously given a diagnosis of type 2 diabetes and who had critical risk factors associated with 
the disease. Recommendations for diabetic screening from the ADA and previous screening 
studies indicate that screening for type 2 diabetes is most effective when all relevant risk factors 
are targeted. For this study, the primary risk factor examined was the elevation of fasting 
capillary whole blood glucose. Included in the study was the identification of other physical 
characteristics that place participants at increased risk for the disease. Screening also included 
cholesterol levels, visual acuity, blood pressure readings, examination of feet for neuropathy, 
pertinent health history information from the ADA’s 2000 Diabetes Risk Test Questionnaire, and 
total body composition assessment indices.
1,6
 Pender’s cognitive perceptual factors,
19
 which are 
outlined as seven major concepts, indicate health-promoting behaviors. These concepts were 
measured by using participant’s overall weight, body mass index, skin-fold metrics, and 
questions concerning overall preventive health behaviors such as, “When was the last time you 
visited your primary care provider? Your dentist?” and questions concerning the taking of 
prescribed medications and exercise patterns. 
 
Procedure 
The human subjects committees of the university and clinical institutions granted approval 
before the study began. Intensive training in all study procedures and assignment of roles for 
research nurses followed. The research nurses were graduate nurses in the Adult/Gerontological 
Nurse Practitioner Program. Two weeks before the initiation of the study, fliers were posted in 
the retirement centers advertising Diabetes Awareness Day. All residents were invited to attend. 
Those who attended Diabetes Awareness Day were given information regarding risk factors, 
signs and symptoms of the disease, and methods to obtain further information. Once this 
information was presented, the study was explained to the residents. Each resident who met 
inclusion criteria for the study was invited to participate. Once written consent was obtained, 
participants were given instructions for the morning of the study. They were required to attend 
two 45-minute appointments for data collection. Participants 
 
were required to fast the morning of their appointments. Afterward, they were given a written 
record of their screening results. Those with abnormal screenings were referred to their local 
primary care provider for further evaluation. 
 
Measures 
A fasting capillary whole blood glucose determination was performed between 8:00 AM and 
10:45 AM by the finger-stick method. According to the ADA’s 2000 recommendations, 
participants with a fasting capillary whole blood glucose reading of > 110 mg/dL were 
considered to have impaired fasting glucose metabolism. Those participants with glucose levels 
> 126 mg/dL were considered to have elevated glucose levels. Participants were given the 
ADA’s 2000 Diabetes Risk Test questionnaire. 1,5 Participants who scored 10 points or higher 
on the risk test were considered to be at significant risk for type 2 diabetes. Determinations of 
fasting capillary whole blood triglyceride levels and high-density lipoprotein cholesterol levels 
were performed between 8:00 AM and 10:45 AM by the finger-stick method. According to the 
ADA’s 2000- 2001 recommendations, fasting capillary whole blood triglyceride readings of ≥ 
250 mg/dL and high-density lipoprotein cholesterol readings of < 35 mg/dL are considered 
abnormal. Blood pressure was measured, and participants with a blood pressure reading of ≥ 
140/90 mm Hg were considered to have elevated blood pressure.
1,5,6
 Each participant underwent 
filament screening of both feet and examination of the feet for ulcers and lesions. Total body 
composition assessments were done by using the Xitron Hydra ECF/ICF multifrequency 
bioelectrical impedance (B1A) device (Bioimpedance Analyzer 4200; Xitron Technologies, Inc., 
San Diego, California) and by performing multiple skinfold circumference measurements. 
 
Data Analysis 
Descriptive statistics were used to illustrate the demographics, fasting capillary whole blood 
glucose levels, and other comorbidity risk factors. Pearson correlation analysis was used to 
determine the relationships between demographic variables, comorbidity factors, and fasting 
capillary whole blood glucose levels. Data were analyzed by using the Statistical Packages for 
the Social Sciences (SPSS 11 [2002] Statistical Analysis; SPSS Inc., Chicago, Illinois). 
 
RESULTS 
Of the 20 participants, 19 had four or more risk factors associated with type 2 diabetes. One of 
the participants had only one risk factor present, and one participant exhibited seven risk factors. 
Weight risk ratio, or obesity, was the most commonly detected risk factor. None of the 
participants were found to have decreased filament sensation or ulcers or lesions on the feet. Ten 
subjects were found to have fasting blood glucose levels ≥ 110 mg/dL, and five of these 
participants had levels ≥ 126 mg/dL—levels indicated for a diagnosis of type 2 diabetes. Of the 
10 participants with elevated glucose levels, eight were female and two were male. 
Approximately half of the men and women in the sample had elevated blood glucose levels. 
 
Table 2 shows the number of participants who had risk factors for microvascular and 
macrovascular complications, as well as type 2 diabetes. Ten of the participants were identified 
as having total cholesterol levels ≥ 200 mg/dL, and six of these participants were taking choles-
terol-reducing medications. Twelve participants were identified as having elevated blood 
pressure, even though all of them were taking prescribed blood pressure medications. 
 
Table 3 shows the number of participants who had elevated fasting blood glucose levels and 
abnormal cholesterol levels, blood pressure, body mass indexes, or scores on the ADA risk test 
questionnaire. The number of participants who had elevated fasting blood glucose levels and 
other comorbidity risk factors was high. Three participants had fasting blood glucose levels ≥ 
110 mg/dL, cholesterol levels ≥ 220 mg/dL, and blood pressure measurements ≥ 140/90 mm Hg. 
Of the three participants who indicated that they had a previous myocardial infarction, two were 
found to have elevated fasting blood glucose levels. However, Pearson’s correlations did not 
reveal statistical significance among the comorbidity risk factors and elevated blood glucose 
levels. 
 
Mean values for indices of percent body fat were 43.9% and 39.8% for women and men, 
respectively. Sagittal diameter, or abdominal fat measurement, was 33.1 cm for men and 36.3 cm 
for women; measures greater than 25 cm are considered elevated. Waist circumferences were 
102 cm and 104 cm for men and women, respectively. Adults 18 years of age and older are 
considered to have central obesity if waist circumference exceeds 102 cm in men and 88 cm in 
women. Elevated percent of body fat indices and increased saggital diameters and waist 
circumferences were all indicative of increased risk for heart disease and type 2 diabetes, 
especially among the female participants. 
 
Responses to questions about personal health care behaviors indicated that 100% of the 
participants had visited their primary care provider at least once during the last year. Sixteen 
participants had visited an optometrist or an ophthalmologist, but only 11 participants had been 
to a dentist. Only five participants stated that they engaged in routine exercise. However, they all 
stated that they spent at least four hours a day in activities that required either walking or 
standing. 
 
DISCUSSION AND IMPLICATIONS 
Nearly 100% of participants had one or more risk factors for type 2 diabetes. Although few 
subjects exhibited fasting blood glucose levels > 200 mg/dL, 50% had fasting blood glucose 
levels above ADA 2000 recommended guidelines. These findings are similar to trends described 
in the literature that suggest that many older adults have undiagnosed hyperglycemia. This study 
also shows that many older adults have comorbidity risk factors associated with type 2 diabetes. 
Unfortunately, the comorbidity risk factors were also untreated or treated at subtherapeutic 
levels. Further, in the majority of cases, primary care providers had not discussed the 
implications of type 2 diabetes and the need for prevention during the past year. 
 
Although this sample size was small, the findings suggest that among older African Americans 
with limited resources, little health care screening for type 2 diabetes has been completed. 
Likewise, this study suggests that among this population, close monitoring of cardiovascular risk 
factors has not occurred. It is apparent from this study that gerontologic nurses need to continue 
screening older adults, especially those with risk factors for type 2 diabetes. ADA 2001 
recommendations and guidelines clearly indicate that early detection and treatment of type 2 dia-
betes are the most beneficial means of managing the complications of this disease, especially 
among older adults.
5
 Because early detection and treatment of type 2 diabetes may also reduce 
the risk of stroke, heart disease, and peripheral vascular disease, screening for associated risk 
factors may help reduce the incidence of morbidity and death among older adults. Interventions 
targeted at modifiable risk factors associated with type 2 diabetes for older adults may also help 
reduce the incidence of complications from heart disease and stroke. 
 
The majority of participants in this study perceived the importance of their own health, as 
demonstrated by their frequent health care visits and their willingness to follow medication 
regimens. However, it is unclear whether this study population understood that they had control 
over their own health. Gerontologic nurses should continue to reinforce the power of healthy 
lifestyle behaviors and the impact of individual choices on protection of overall health. 
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